All News Dx & Vx Co., Ltd.

Equities

A180400

KR7180400004

End-of-day quote Korea S.E. Other stock markets 23:00:00 27/05/2024 BST			5-day change	1st Jan Change
4,100 ^KRW	-0.73%		-0.73%	-30.63%

2023	Dx&Vx Co-Develops Bio-Healthcare Big Data Platform with LG CNS	CI
2023	Dx & Vx Co., Ltd. completed the acquisition of Avixgen, Inc. from a group of sellers	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Dx&Vx Co-Develops Bio-Healthcare Big Data Platform with LG CNS	12-20	CI
Dx & Vx Co., Ltd. completed the acquisition of Avixgen, Inc. from a group of sellers	27/06/23	CI
Dx & Vx Co., Ltd. announced that it has received KRW 9.223311402 billion in funding from Renaissance Asset Management and other investors	13/06/23	CI
Dx & Vx Co., Ltd. agreed to acquire Avixgen, Inc. from Renaissance Asset Management, Nouveau International Co., Ltd., Lee Mi-ja, Seo Jin - young, Kim Jae-hyun , Cho Il-hyun,Park So -yeon, Jeong Ja -woon, Kim Young- ju, Yang Young-jin, Kim Hye -min and Um In-kyung for KRW 9.2 billion.	23/05/23	CI
DxVx Appoints Kevin Kwon as New President	16/05/23	CI
DxVx Appoints Yong Gu Lee as CEO	16/05/23	CI
Dx & Vx Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	13/04/23	CI
Dx & Vx Co., Ltd. announced that it expects to receive KRW 9.223311402 billion in funding from Renaissance Asset Management and other investors.	06/04/23	CI
Dx & Vx Co., Ltd. announced that it has received KRW 17 billion in funding	05/10/22	CI
Dx & Vx Co., Ltd. completed the acquisition of Korea Biopharm Co., Ltd. from Jang, Byung Ha, Heo, Won Jung, Kim, Min E, Jang, So Yeon, Kim, Sung Gon and Hyun, Mi Ok.	03/10/22	CI
Dx & Vx Co., Ltd. agreed to acquire Korea Biopharm Co., Ltd. from Jang, Byung Ha, Heo, Won Jung, Kim, Min E, Jang, So Yeon, Kim, Sung Gon and Hyun, Mi Ok for approximately KRW 15 billion.	14/09/22	CI
Dx & Vx Co., Ltd. announced that it expects to receive KRW 1.78 billion in funding	06/09/22	CI
Cancer Rop Co., Ltd. announced that it expects to receive KRW 20 billion in funding	29/08/21	CI
Cancer Rop Co., Ltd. announced that it has received KRW 999.99252 million in funding	28/06/20	CI
Cancer Rop Co., Ltd. announced that it expects to receive KRW 999.99252 million in funding	17/06/20	CI
D S and partners limited company cancelled the acquisition of 10.2% stake in GI Innovation, Inc. from Cancer Rop Co., Ltd..	28/04/20	CI
Cancer Rop Holdings Co., Ltd. cancelled the acquisition of 3.4% stake in Cancer Rop Co., Ltd. from Myungji Global Bio Fund.	10/07/19	CI
Ds&Partners signed a contract to acquire 10.2% stake in GI Innovation, Inc. from Cancer Rop Co., Ltd. for KRW 7.5 billion.	28/04/19	CI
Resort Savers, Inc. Announces Medical Distribution Partnership with South Korea based CancerROP	16/07/18	CI
GI Innovation, Inc. announced that it has received KRW 4.999995 billion in funding from Cancer Rop Co., Ltd.	12/07/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Dx & Vx Co., Ltd.

Equities

A180400

KR7180400004

All News

Filters